Opinion
The NIH and FDA nominees are surprisingly strong
Watching last week’s confirmation hearings for Jayanta Bhattacharya and Marty Makary, President Donald Trump’s nominees to lead the National Institutes of Health and the Food and Drug Administration, respectively, I was struck by how normal the candidates were.
Jay Bhattacharya, nominee for National Institutes of Health director, and FDA pick Marty Makary clear key Senate committee.
Senators who once denounced the NIH nominee’s ideas as “fringe” had nothing to say about pandemic lockdowns, mandates, or ...
Trump's nominee for NIH director once stirred major controversy for criticizing lockdowns, mask mandates, and school closures ...
Judges criticized Jay Bhattacharya's expert witness testimony as untrustworthy, but a Stanford colleague described him as a ...
10don MSN
Dr. Jay Bhattacharya, who opposed Covid lockdowns, is set to appear at a Senate confirmation hearing on Wednesday for his ...
Stanford University professor Jay Bhattacharya appeared before the Senate Committee on Health, Education, Labor, and Pensions for his confirmation hearing as the next director of the National ...
Dr. Jay Bhattacharya said he would seek ethical alternatives to using medical research based on cell lines taken from fetal ...
As Marty Makary and Jay Bhattacharya sail through the Senate health committee vote, Weldon's confirmation hearing is canceled ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback